Clinical News

Emily Strouphauer, BSA: Linking Pediatric Psoriasis to Anxiety, Depression

7 hours ago

By Tim Smith

In her HCPLive interview, Emily Strouphauer, BSA, spoke about her team’s recent findings on the association between pediatric psoriasis and anxiety and depression.

Raj Chovatiya, MD, PhD: Psoriasis Treatment Developments, FDA Approvals in 2022

8 hours ago

By Tim Smith

In an interview with HCPLive, Dr. Chovatiya spoke about recent FDA approvals for psoriasis treatments, including deucravacitinib, spesolimab, roflumilast, and tapinarof.

Lawrence Eichenfield, MD: Phase 3 Trial Data on Ruxolitinib for Atopic Dermatitis

10 hours ago

By Tim Smith

During his HCPLive interview, Dr. Eichenfield described the results from the phase 3 TRuE-AD trials testing ruxolitinib for atopic dermatitis, including how the findings might affect treatment for vitiligo or psoriasis.

Roflumilast Clinical Development Program in Plaque Psoriasis

12 hours ago

By Leon Kircik, MD

Leon Kircik, MD, discusses the recent FDA approval of roflumilast for plaque psoriasis treatment.

PDE4 in Plaque Psoriasis

12 hours ago

By Leon Kircik, MD

Leon Kircik, MD, provides an overview of PDE4 inhibitors in the treatment of plaque psoriasis.

Crisis Point: Insulin Access in the United States

A special episode focuses on the issue of insulin accessibility and affordability in the United States, with four experts in the diabetes arena weighing in on the topic.

Conference Coverage

View All >>

Heather Woolery-Lloyd, MD, FAAD: Interview on Common Skin of Color Dermatoses

November 23, 2022

By Tim Smith

An interview on the SDPA 2022 presentation of Dr. Woolery-Lloyd in which she discusses dermatoses affecting patients of color.

Orit Markowitz, MD: Artificial Intelligence, Patient Knowledge on Skin Cancer

November 23, 2022

By Tim Smith

A discussion with Dr. Markowitz on her presentation from SDPA 2022, during which she described various gaps in knowledge on skin health and future innovations she hoped to see.

Ruxolitinib Cream Improves Atopic Dermatitis Pain, Anxiety and Depression Over 52 Weeks

November 23, 2022

By Kevin Kunzmann

New long-term phase 3 data show adults and adolescents both improved measures of quality of life when treated with either of 2 doses of ruxolitinib cream.

Orit Markowitz, MD: How to Distinguish Skin Cancer from Less Dangerous Skin Conditions

November 22, 2022

By Tim Smith

An interview with Dr. Markowitz on her presentation at SDPA 2022 presentation entitled ‘Skin of Color,’ regarding differentiating skin cancer from other conditions.

Video Series

View All >>

Roflumilast Clinical Development Program in Plaque Psoriasis

PDE4 in Plaque Psoriasis

Limitations of Injectable Insulin in Type 1 and Type 2 Diabetes

Types of Insulin Formulations for Type 1 and Type 2 Diabetes

Pegcetacoplan for Treatment of Geographic Atrophy

Pathophysiology, Treatment Targets and Options in Geographic Atrophy

Multidisciplinary/Team Based Approach for Lipid Management

Emerging Therapies for Hypercholesterolemia

Dual Orexin Receptor Antagonist (DORA) for Treatment of Insomnia

Sleep and Wakefulness Pathways